Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marylyn M Addo

Showing results (81-90 of 183) with videos related to

Pageof 19
Sort By:
Biomolecules|August 16, 2020
Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101)Mahir Karakas, Dominik Jarczak, Martin Becker, et al.
Gut|May 24, 2019
No link between male infertility and HEV genotype 3 infectionThomas Horvatits, Domenica Varwig-Janssen, Julian Schulze Zur Wiesch, et al.
Cytokine|December 18, 2022
Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infectionLeon Cords, Robin Woost, Silke Kummer, et al.
Viruses|February 28, 2023
Clinical Outcomes of SARS-CoV-2 Breakthrough Infections in Liver Transplant Recipients during the Omicron WaveAnna Herting, Jacqueline Jahnke-Triankowski, Aenne Harberts, et al.
Cell Reports. Medicine|July 20, 2022
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccineLeonie M Weskamm, Anahita Fathi, Matthijs P Raadsen, et al.
Infection|October 25, 2025
Five-Year German PrEP cohort reveals high HIV protection and persistent STI burden: implications for individualized and flexible prevention strategiesMaher Almahfoud, Lukas Weimann, Guido Schäfer, et al.
Communications Medicine|April 11, 2023
Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 diseaseKatrin Hufnagel, Anahita Fathi, Nadine Stroh, et al.
Plos Medicine|November 5, 2004
Limited durability of viral control following treated acute HIV infectionDaniel E Kaufmann, Mathias Lichterfeld, Marcus Altfeld, et al.
Brain Communications|December 30, 2020
Frequent neurocognitive deficits after recovery from mild COVID-19Marcel S Woo, Jakob Malsy, Jana Pöttgen, et al.
European Journal of Neurology|May 9, 2023
History of cerebrovascular disease but not dementia increases the risk for secondary vascular events during SARS-CoV-2 infection with presumed Omicron variant: a retrospective observational studyChristina Mayer, Marcel S Woo, Thomas Theo Brehm, et al.
Pageof 19

Showing results (81-90 of 183) with videos related to

Sort By:
Pageof 19
Biomolecules|August 16, 2020
Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101)Mahir Karakas, Dominik Jarczak, Martin Becker, et al.
Gut|May 24, 2019
No link between male infertility and HEV genotype 3 infectionThomas Horvatits, Domenica Varwig-Janssen, Julian Schulze Zur Wiesch, et al.
Cytokine|December 18, 2022
Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infectionLeon Cords, Robin Woost, Silke Kummer, et al.
Viruses|February 28, 2023
Clinical Outcomes of SARS-CoV-2 Breakthrough Infections in Liver Transplant Recipients during the Omicron WaveAnna Herting, Jacqueline Jahnke-Triankowski, Aenne Harberts, et al.
Cell Reports. Medicine|July 20, 2022
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccineLeonie M Weskamm, Anahita Fathi, Matthijs P Raadsen, et al.
Infection|October 25, 2025
Five-Year German PrEP cohort reveals high HIV protection and persistent STI burden: implications for individualized and flexible prevention strategiesMaher Almahfoud, Lukas Weimann, Guido Schäfer, et al.
Communications Medicine|April 11, 2023
Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 diseaseKatrin Hufnagel, Anahita Fathi, Nadine Stroh, et al.
Plos Medicine|November 5, 2004
Limited durability of viral control following treated acute HIV infectionDaniel E Kaufmann, Mathias Lichterfeld, Marcus Altfeld, et al.
Brain Communications|December 30, 2020
Frequent neurocognitive deficits after recovery from mild COVID-19Marcel S Woo, Jakob Malsy, Jana Pöttgen, et al.
European Journal of Neurology|May 9, 2023
History of cerebrovascular disease but not dementia increases the risk for secondary vascular events during SARS-CoV-2 infection with presumed Omicron variant: a retrospective observational studyChristina Mayer, Marcel S Woo, Thomas Theo Brehm, et al.
Pageof 19